Browse
Explore conditions, clinical trials, and the organisations running them.
Up to: Disorder of glycolysis · Anemia due to erythrocyte enzyme disorder · Congenital nonspherocytic hemolytic anemia
Non-spherocytic hemolytic anemia due to hexokinase deficiency
Nonspherocytic hemolytic anemia due to hexokinase deficiency (NSHA due to HK1 deficiency) is a very rare conditionmainly characterized by severe, chronic hemolysis, beginning in infancy. Approximately 20 cases of this condition have been described to date. Signs and symptoms of hexokinase deficiency are very similar to those of pyruvate kinase deficiency but anemia is generally more severe. Some affected individuals reportedly have had various abnormalities in addition to NSHA including multiple malformations, panmyelopathy, and latent diabetes.Itcan be caused by mutations in the HK1 gene and is inherited in an autosomal recessive manner. Treatment may include red cell transfusions for those with severe anemia.
This condition has no sub-types.